Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Accumulated Expenses (2019 - 2026)

Analysis

Starling Oncology (STLN) Accumulated Expenses (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.44 Mn
Mar 31, 2026 24.30 Mn
Dec 31, 2025 20.64 Mn
Sep 30, 2025 22.79 Mn
Jun 30, 2025 22.89 Mn
Mar 31, 2025 23.43 Mn
Dec 31, 2024 21.09 Mn
Sep 30, 2024 15.44 Mn
Jun 30, 2024 12.83 Mn
Mar 31, 2024 18.36 Mn
Dec 31, 2023 14.00 Mn
Sep 30, 2023 12.72 Mn
Jun 30, 2023 14.13 Mn
Mar 31, 2023 12.25 Mn
Dec 31, 2022 14.60 Mn
Sep 30, 2022 16.15 Mn
Jun 30, 2022 17.61 Mn
Mar 31, 2022 14.52 Mn
Dec 31, 2021 13.92 Mn
Sep 30, 2021 2.63 Mn